Aproliferin: a modulator of proliferative potential

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• Cellular differentiation involves progressive changes in cell phenotype and proliferative capacity.
• Three distinct stages of adipocyte differentiation (growth arrest, non-terminal, and terminal) are identified in 3T3-T mesenchymal stem cells.
• Terminal differentiation is characterized by irreversible loss of proliferation and commitment to adipocyte-specific gene expression.

Purpose of the Study:

• To identify and characterize factors that induce the transition from non-terminal to terminal differentiation in adipocytes.
• To investigate the molecular mechanisms underlying aproliferin-induced terminal differentiation.

Main Methods:

• Partial purification of a differentiation-inducing protein from human plasma.
• Treatment of 3T3-T adipocytes with the purified protein (aproliferin).
• Analysis of cellular protein synthesis changes following aproliferin treatment.
• Assessment of aproliferin's specificity by testing various pharmacological and biochemical agents.

Main Results:

• A protein, designated aproliferin (approx. 45,000 mol. wt.), was purified from human plasma.
• Aproliferin induced the transition of 3T3-T adipocytes from a non-terminal to a terminal differentiation state.
• Aproliferin is trypsin, acid, and heat labile.
• Terminal differentiation induced by aproliferin correlated with alterations in the synthesis of specific cellular proteins.
• The effect of aproliferin was highly specific, not mimicked by other agents.

Conclusions:

• Aproliferin is a novel protein capable of inducing terminal adipocyte differentiation.
• Aproliferin may represent a new class of molecules that regulate cell differentiation and induce irreversible functional changes.
• This discovery opens avenues for understanding and manipulating cell fate determination.